83.78
+1.75(+2.13%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
2423
First IPO Date
January 17, 2020
| Name | Title | Pay | Year Born |
| Ms. Yiling Yang | Chief Financial Officer, Accounting Supervisor, Deputy GM & Secretary | 0 | 1975 |
| Ms. Liyu Shi | Deputy General Manager | 0 | 1980 |
| Mr. Li Sun | Chairman & GM | 0 | 1966 |
| Ms. Shiyuan Wang | Technical Director of R&D Center | 0 | 1973 |
| Mr. Linzhong Zhang | Deputy General Manager | 0 | 1969 |
| Ms. Meihua Yang | Deputy General Manager | 0 | 1972 |
| Mr. Jiehua Zheng | Deputy General Manager | 0 | 1980 |
| Ms. Liping Lai | Vice President & Director | 0 | 1971 |
| Ms. Ping Zou | Director of Intellectual Property Management | 0 | 1966 |
| Mr. Weidong Zhou | Deputy General Manager | 0 | 1971 |
Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs using genetic engineering technology in China. It offers formulations, reagents, and APIs, as well as custom-manufacturing services. The company was founded in 1996 and is based in Xiamen, China.